Men’s urological needs refer to the medical and surgical conditions that affect the male urinary tract system and reproductive organs. Some of the common men’s urological needs include:
- Prostate health: The prostate is a gland located just below the bladder and is important for male reproductive health. Conditions such as benign prostatic hyperplasia (BPH) or prostate cancer can affect prostate health.
- Urinary tract infections (UTIs): UTIs are common in men and can cause pain and discomfort during urination. They are caused by bacterial infections in the urinary tract system.
- Erectile dysfunction: Erectile dysfunction (ED) is the inability to achieve or maintain an erection sufficient for sexual intercourse. ED can be caused by several factors such as nerve damage, psychological issues, or underlying medical conditions.
- Infertility: Infertility is the inability to conceive a child. Male infertility can be caused by several factors such as low sperm count, poor sperm motility, or genetic conditions.
- Testicular health: Testicles are important for male reproductive health. Conditions such as testicular cancer, torsion, or trauma can affect testicular health.
- Incontinence: Incontinence is the loss of bladder control and can be caused by several factors such as prostate surgery, nerve damage, or medication side effects.
- Kidney stones: Kidney stones are hard deposits that form in the kidneys and can cause pain and discomfort during urination.
- Urological cancers: Men can develop several types of urological cancers, including prostate cancer, bladder cancer, and kidney cancer.
A urologist can address these concerns, however a pharmacy-led model of care developed by Brad Butt, called Mens Health Downunder has offered an alternative to certain urological needs of the male adult population over the past 10 years.
Initially commencing in Canberra and now in 9 locations across Australia, the operation is run by a group of Australian pharmacists that provide rehabilitation solutions and cost-effective endorsed medical grade treatments for men with urological health issues. Mens Health Downunder provides products that are medical grade and specifically tailored for individuals with urological or sexual health issues backed by evidence-based solutions and pharmaceutical advice.
Mens Health Downunder exists to address the growing need for men to access quality health advice, break the stigma around urological health and reduce the embarrassment so men openly ask questions and confidently address health concerns. No concern is off limits.
Australian Health Journal met with Brad to hear about his journey, Mens Health Downunder and the impact the pharmacy-led model of care has had on patient’s urological as well as mental health.
Brad’s mission is to also raise awareness for prostate cancer. Prostate cancer is now the most common cancer diagnosed in Australia with expectations of aggressive diagnosis to double by 2028, overtaking breast cancer. Interestingly, media tends to focus on breast cancer more than prostate cancer. Often this is because of the stigma associated with prostate cancer. Men suffer in silence and are less likely to seek medical diagnosis and treatment. However, the stigma that surrounds prostate cancer and men’s health is a significant barrier that is being addressed, by Brad and his team of pharmacists.
-
30 years on, Viertel Foundation legacy continues
One of Australia’s largest charitable foundations, the Sylvia and Charles Viertel Charitable Foundation, is celebrating three decades of transforming Australian healthcare – with more than $90 million invested in medical research and a legacy of breakthroughs that are saving lives. Viertel Fellowships support some of Australia’s best and brightest researchers and clinicians, with 70 Fellowships awarded to date.
-
State of Private Hospitals sector in Australia
During Mr Roff’s working career at APHA he has represented the private hospitals sector to nine different Federal Health Ministers and eight Prime Ministers. He believes the government should take steps to regulate the health insurance industry to protect consumers and ensure that Australians have access to affordable and comprehensive healthcare services.
-
Nuclear medicine funding a win for men with prostate cancer
Australian men with higher risk prostate cancer now have access to a nuclear medicine scan to help detect and treat metastatic disease, after it was listed on the Medical Benefits Schedule (MBS) from 1st July 2022.
In 2021 over 18,000 Australian men were diagnosed with prostate cancer, resulting in over 3,000 lives being lost – and making prostate cancer Australia’s second most common cause of cancer death in men.
Australian Health Journal spoke with AANMS President Associate Professor Sze Ting Lee and Dr Geoff Schembri on the MBS listing and the efforts to get it listed.
